Chemomab Therapeutics (CMMB) Tops Q1 EPS by 0c

Chemomab Therapeutics (NASDAQ: CMMB) reported Q1 EPS of ($0.01), $0.00 better than the analyst estimate of ($0.01).

For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Parker-Hannifin (PH) Declares $2.00 Quarterly Dividend; 0.8% Yield
• Holcim to acquire Fermacell from James Hardie for EUR 840M